Evidence map›Paper›PMID 31387924›Full record

ArticleCancer research2019

Lucia Casadei, Federica Calore, Danielle A Braggio, Abeba Zewdu, Ameya A Deshmukh, Paolo Fadda, Gonzalo Lopez, Martin Wabitsch, Chi Song, Jennifer L Leight and 4 more

Abstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Circulating Biomarkers in Sarcoma.Current oncology reports · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Oncogenic Functions of Alternatively SplicedInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Lucia CasadeiThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Federica CaloreDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Danielle A BraggioThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Abeba ZewduThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Ameya A DeshmukhThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Paolo FaddaDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Gonzalo LopezThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Martin WabitschDepartment of Pediatrics and Adolescent Medicine Division of Paediatric Endocrinology and Diabetes Centre for Hormonal Disorders in Children and Adolescents, Ulm University Hospital, Germany.
Chi SongCollege of Public Health, Division of Biostatistics, The Ohio State University, Columbus, Ohio.
Jennifer L LeightThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.ORCID 0000-0003-4510-1086
Valerie P GrignolThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Dina LevDepartment of Surgery "B," Sheba Medical Center and The Tel Aviv University, Tel Aviv, Israel.
Carlo M CroceDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Raphael E PollockDepartment of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio. raphael.pollock@osumc.edu.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USOhio Department of Health · USSheba Medical Center · ILThe Ohio State University Wexner Medical Center · USUniversity Hospital Ulm · DE

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Tissue and Pathology ResourcesU54CA168512 · NCI · SARC · PI REINKE, DENISE · 2012 to 2016
$11.0M
Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4M
NCI NIH HHS P30 CA016058NCI NIH HHS R35 CA197706NCI NIH HHS U54 CA168512
6 · The paper itself

Abstract

Dedifferentiated liposarcoma (DDLPS) is frequently diagnosed late, and patients typically respond poorly to treatments. DDLPS is molecularly characterized by wild-type p53 and amplification of the

Indexed as

AdipocytesExtracellular VesiclesHumansLiposarcomaProto-Oncogene Proteins c-mdm2Stem CellsTumor MicroenvironmentMDM2 protein, humanProto-Oncogene Proteins c-mdm2

Identifiers

PMID31387924
PMCPMC6774856
OpenAlexW2964698060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.